Handelsbanken Fonder AB Trims Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Handelsbanken Fonder AB lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 139,009 shares of the medical equipment provider’s stock after selling 2,039 shares during the quarter. Handelsbanken Fonder AB’s holdings in Intuitive Surgical were worth $46,896,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently modified their holdings of the company. OFI Invest Asset Management purchased a new position in shares of Intuitive Surgical during the third quarter valued at about $25,000. Baystate Wealth Management LLC grew its holdings in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the period. Headinvest LLC purchased a new stake in Intuitive Surgical in the third quarter worth about $28,000. Stone House Investment Management LLC grew its holdings in Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares during the period. Finally, Truvestments Capital LLC grew its holdings in Intuitive Surgical by 137.2% in the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 59 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Fredrik Widman sold 5,041 shares of the business’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the completion of the sale, the vice president now owns 110 shares in the company, valued at $43,677.70. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 248,418 shares of company stock worth $95,927,097. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $366.34 on Monday. The company has a market cap of $129.85 billion, a P/E ratio of 66.13, a P/E/G ratio of 5.69 and a beta of 1.36. The firm’s fifty day moving average is $386.84 and its two-hundred day moving average is $343.86. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.00 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. BTIG Research increased their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday. Piper Sandler increased their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday. Truist Financial increased their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Finally, Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.